|
 |
Company Study of Huadong Medicine
|
 
Huadong Medicine Co., Ltd. was founded in March, 1993, based on the medicine distribution network in Hanzhou, capital of Zhejiang province, after a government-oriented restructuring. On December 22, 1999, the company went public on the Shenzhen Stock Exchange and raised around CNY288 million through issuing 5,000 shares. Its main business covers the production and sale of chemical medicine and traditional Chinese medicine.
Structure of Main Business Revenue of Huadong Medicine
(Unit: CNY billion)
Source: ResearchInChina
Huadong Medicine's main business revenue covers two parts-pharmacy industry and pharmacy business. Since the gross profit margin of pharmacy industry is much higher than the pharmacy business, Huadong Medicine has been making vigorous efforts to open up the market of the pharmacy industry, which has made the proportion of its pharmacy industry to the total main business revenue increase year by year. This is one of the key reasons that the company's performance rose gradually in the recently years.
According to the company's announcement on April 3, 2008, Huadong Medicine plans to acquire 78.87% stake in Xi'an Bohua Pharmaceutical Co., Ltd. and 65% stake in the latter's subsidiary named Shaanxi Jiuzhou Medicine Co., Ltd. for CNY98 million. The acquisition, if done, will not only help the company reinforce its strength in special pharmaceutical raw materials, but also enter the narcotic market with high barriers to enter.
1. Huadong Medicine Company Profile
1.1 Brief Introduction
1.2 Shareholders of Huadong Medicine
1.3 Pharmacy Policies
1.3.1 Hospital to Follow the Measures for Prescription Management
1.3.2 Industry Concentration to Be Lifted Greatly by Improved Environment Protection Standards
2. Main Business of Huadong Medicine
2.1 Products
2.2 Pharmacy Industry
2.2.1 Immunosuppressant Products
2.2.2 Diabetes Medicines
2.2.3 Anti-peptic ulcer medicine
2.2.4 Pharmaceutical Raw Material
2.2.5 Summery on Pharmacy Industry
2.3 Pharmacy Business
2.4 Marketing and Development Strategies
2.4.1 Marketing Strategy
2.4.2 Development Strategy
3. Financial Status of Huadong Medicine Co., LTD
3.1 Solvency
3.2 Operation Efficiency
3.3 Profitability
3.4 Growing Ability
3.5 Financial Structure
3.6 Cash Flow Ratio
4. SWOT Analysis
4.1 Strength
4.2 Weakness
4.3 Opportunities
4.4 Threats
5. Summarization
Huadong Medicine's Shareholding Structure
Huadong Medicine's Organization Structure
Huadong Medicine's Top Ten Shareholders As of 2007
Huadong Medicine's Main Products
Huadong Medicine's Main Businesses, 2003-2007
Huadong Medicine's Business Structure in 2007
Huadong Medicine's Gross Profit Margin, 2003-2007
Companies Producing Main Products of Huadong Medicine
Huadong Medicine's Sales Revenue by Product, 2007
Huadong Medicine's Sales Revenue of Main Products
Huadong Medicine's Pharmacy Industry Performance, 1998-2007
Huadong Medicine's Distribution Targets in 2006
Development Thought of the Western Medicine Sector
Huadong Medicine's Sales Revenue and Growth by Product, 2004-2008
Distribution of China Immunosuppressant Market Share
Purchasing Value of Sampled Immunosuppressant in Typical Cities of China
Growth Rate of Sampled Immunosuppressant in Typical Cities of China
Four Families in Cyclosporine Market
Immunosuppressant Markets in the U.S. and China
China Diabetes Market Scale and Its Growth, 2002-2006
Market Shares of Sampled Diabetes Medicines, 2005-2006
Market Shares of Pioglitazone Producers in 16 Chinese Sampled Cities
Top Ten Diabetes Medicine Producers in China, 2004-2006
Huadong Medicine's Revenue, Growth Rate and Profit Margin from Diabetes and Peptic Medicine, 2004-2008
Main Peptic Ulcer Drugs Applied in Clinic in China and their Market Shares
Proton Pump Inhibitor Main Products and Market Shares, 2004-2006
Pantoprazole Market Share and Growth, 2004-2006
Competition among Pantoprazole Producers
Competition among Omeprazole Producers
Huadong Medicine's Sales Revenue and Growth Rate, 2004-2008
Huadong Medicine's Specific Quality Standards for Bulk Raw Material Purchasing
Growth of Huadong Medicine's Business 1998-2007
Huadong Medicine's Distribution Network
Huadong Medicine's Production, Sales, and Technical Team, 2006-2007
Products of General Agents above Designated Scale, 2005-2007
Ornidazole Applied for Gynecological Inflammation Disease, 2004-2006
Market Shares of Ornidazole
Huadong Medicine's Solvency
Huadong Medicine's Operation Efficiency
Huadong Medicine's Profitability
Huadong Medicine's Growing Ability
Huadong Medicine's Financial Structure
Huadong Medicine's Cash Flows
China Animal Vaccine Industry Report, 2009-2010 China’s animal vaccine market has grown up steadily despite all the twists and turns in the livestock and poultry breeding market over the past four years. In 2009, the market scale reached around RMB... Global and China Medical Devices Industry Report, 2009 The development of medical devices industry differs afar in developed countries and developing countries. In emerging markets like China and India, it is the economic growth that drives the expansion ... China Medical Sales and Medical Device Market Report, 2008 In the recent years, Chinese medical device market developed rapidly. During Jan to Nov 2008, 915 medical device companies were together realized a sales revenue of CNY 63.6 billion, accounting for 9.... China Diagnostic Reagent Market Report, 2007-2009 China's diagnostic reagent industry had lagged behind other countries for a long time. Since 1980s, China's reagent for clinical diagnosis has started entering the industrialization process, following... China Portable Medical Devices Report, 2007-2008 In 2007, the market scale of portable medical devices in China was CNY 24.56 billion, up by 16.5% year on year, which was mainly contributed by the purchase growth from large hospitals.
China ... Investment Report of China Medical Industry, 2000-2008 China is the largest country in the world in terms of population. Its population of 1.3 billion people provides a huge market for the development of China's medical service industry. The existing medi... Company Study of Huadong Medicine Huadong Medicine Co., Ltd. was founded in March, 1993, based on the medicine distribution network in Hanzhou, capital of Zhejiang province, after a government-oriented restructuring. On December 22, 1... China Medical Device Industry and Listed Company Report, 2008 China is a large medical apparatus and instruments producer in both Asia and the world. China, as one of the top ten emerging markets in the world's medical apparatus and instruments industry, had a m... Political Influence Study of China Medical Industry, 2007 China started the cut down the medicine price dramatically for the 21st time in Jan, 2007, and the management board also stated that it will continue to squeeze the medicine price foams for many times... China Medical Devices Market Report, 2007 Presently, the global sales revenue of medical device amounted to about USD 250 billion. Developed countries and regions take the majority of market shares, among which America takes 40%, Europe 30%, ... Company Study of Jiangsu Hengrui Medicine Jiangsu Hengrui Medicine Co., Ltd. mainly produces anti-tumor drugs, anti-infectious drugs, antibiotic drugs and drugs for operation, and the first kind generates most of the company's profit. In the ... China Medicated Health Product Industry Report, 2007 It's estimated that in the forthcoming couple of years, the growth rate of the sales income of the medical industry will remain at 15-17%. In the long term, thanks to the highest growth speed, China's... China Medical Industry Report, 2007 In the first quarter of 2007, the main business income of the whole medical manufacturing industry increased steadily, and growth margin of total profit exceeded 10% of the main business income. In ad... China Medical Sales Channel Report, 2006-2007 In the first three quarters of 2006, the total sales value of top seven medicine merchandises in China amounted to RMB 211.838 billion, up by 8.07% year-on-year, among which, the total sales value of ... China Medical Device Industry Report, 2005-2006 By the end of Dec 2005, the total assets of China medical device industry has reached RMB33.856 billion, in Q4 2005, the sales revenue of China medical device industry was RMB10.429 billion, increased... China Medical Devices Market Report, 2005 According to HIMA forecast, global medical instrument sales will reach $260 billion in 2006. The US medical instrument growth rate maintained at 9 percent.
According to the forecast of the 10th five... China Woundcare Products: Supplier Capability Report, 2005 China is poised to become one of the world’s largest exporters of woundcare products. Their market share is expected to increase further as suppliers boost production, gain CE marking and FDA approval... China Medical Imaging: Supplier Capability Report, 2005 China is poised to be a large exporter of medical imaging equipment in the world. Their market share is expected to increase further as suppliers boost production, gain CE marking and FDA approvals an...
|